News Image

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

Provided By GlobeNewswire

Last update: May 13, 2024

- Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP)

Read more at globenewswire.com

GENERATION BIO CO

NASDAQ:GBIO (7/30/2025, 2:45:31 PM)

4.3001

-0.11 (-2.49%)



Find more stocks in the Stock Screener

GBIO Latest News and Analysis

Follow ChartMill for more